🔎 Trials Near Me

Hjem › Akut myelogen leukemi › Wisconsin › Milwaukee

Kliniske studier for Akut myelogen leukemi i Milwaukee, WI

17 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Milwaukee (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekruttererFase 2
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Medical College of Wisconsin, Milwaukee
  • og 12 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564390

Ivosidenib as Post-HSCT Maintenance for AML

RekruttererFase 2
  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Alder 18 til 75 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06707493

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Aurora Cancer Care-Milwaukee, Milwaukee
  • Aurora Saint Luke's Medical Center, Milwaukee
  • Aurora Sinai Medical Center, Milwaukee
  • og 9 flere
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RekruttererObservasjonsstudie
  • Children's Hospital of Wisconsin, Milwaukee
Alder 0 til 38 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06131801

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Medical College of Wisconsin, Milwaukee
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Medical College of Wisconsin, Milwaukee
Alder 18 til 59 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Medical College of Wisconsin, Milwaukee
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekruttererFase 3
  • Children's Hospital of Wisconsin, Milwaukee
6 Months – 21 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04293562

A Study of BGB-11417 in Participants With Myeloid Malignancies

RekruttererFase 1/2
  • Medical College of Wisconsin, Milwaukee
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT04771130

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RekruttererFase 3
  • Froedtert & Medical College of Wisconsin, Milwaukee
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RekruttererFase 1
  • Froedtert & Medical College Clinics, Milwaukee
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06001788

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

RekruttererFase 1
  • Medical College of Wisconsin, Milwaukee
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06656494

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservasjonsstudie
  • Children's Hospital of Wisconsin, Milwaukee
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

RekruttererFase 2/3
  • Froedtert & Medical College of Wisconsin, Milwaukee
Alder 18 og eldre · Alle kjønn · Oppdatert 30. apr. 2026 · NCT04256317

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RekruttererFase 1
  • Medical College of Wisconsin Cancer Center, Milwaukee
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mar. 2026 · NCT05735184

Venetoclax to Augment Epigenetic Modification and Chemotherapy

RekruttererFase 1
  • Children's Wisconsin, Milwaukee
Alder 1 til 25 · Alle kjønn · Oppdatert 12. jan. 2026 · NCT05317403

Akut myelogen leukemi-studier i andre byer

Andre studier i Milwaukee

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.